Patient Capital

What this book actually teaches

Most capital flows to investments with short payback horizons because the investors who control that capital have short time horizons themselves. Victoria Ivashina and Josh Lerner's "Patient Capital" (2021) examines the exceptions: the institutions — sovereign wealth funds, endowments, family offices, some pension funds — that can credibly commit to long investment horizons and what that commitment makes possible.

The central argument is that patient capital — money committed for years or decades without the pressure to mark-to-market quarterly or satisfy near-term redemption demands — is a genuinely different input into the economy than ordinary capital. It enables investments that no short-horizon investor would fund: infrastructure with 30-year payback periods, basic research, venture bets in technology cycles that play out over a decade, turnarounds requiring operational transformation over five or more years. The book's empirical contribution is documenting the gap between the theory of patient capital and its practice — most institutions that claim to invest long do not actually behave differently from their shorter-horizon peers.

Ivashina and Lerner draw on Harvard Business School case research and proprietary data to examine how sovereign wealth funds, endowments, and large family offices actually deploy capital, where they succeed, and where governance problems, political interference, and agency costs undermine their structural advantage. The sovereign wealth fund section is particularly detailed, examining how political mandates and domestic-return pressures erode the long-horizon advantage that these funds nominally possess. The private equity and venture sections examine how fund structures — with their 10-year fixed lives and 2-and-20 compensation — create shorter incentive horizons than their marketing suggests.

The book is aimed at institutional investors, asset managers, policy professionals, and academics working at the intersection of finance and economic growth. It reads as a serious research synthesis, not a practitioner playbook.

The limitations are worth noting. The book's empirical base leans heavily on case studies and proprietary data sets that are not fully reproducible, which limits independent verification of some conclusions. The policy recommendations — improve governance of sovereign wealth funds, restructure incentives in long-horizon vehicles — are directionally correct but underspecified. And the book's scope, while intellectually rich, stops short of the most actionable question for most institutional investors: how exactly does a mid-sized pension fund or endowment practically lengthen its investment horizon given its existing obligations and governance structure?

For institutional investors, policy economists, and academics interested in the gap between long-horizon capital theory and practice, this is the most rigorous treatment of the subject available. It does not flatter the field — the finding that most patient capital is not actually patient is the book's most important and least comfortable conclusion.

Read next

About Victoria Ivashina

Read more from Victoria Ivashina and explore the full bibliography on ClearValue Books.